Intensive Care Therapy of Covid-19 Disease in Germany

NCT04455451 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2054

Last updated 2022-01-12

No results posted yet for this study

Summary

Multi-center retrospective and prospective observational study of Covid-19 patients with severe or critical illness treated on a German ICU

Conditions

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Peter Rosenberger, MD, PhD · University Hospital Tübingen

  • Harry Magunia, MD · University Hospital Tübingen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-06
Primary Completion
2021-08-15
Completion
2021-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04455451 on ClinicalTrials.gov